Results:
The baseline characteristics of the patients, that is, characteristics of the patients before their pregnancies were confirmed, are shown in Table 1. Baseline characteristics included PTSD history as well as age, BMI and location . All of these women were taking Prazosin for PTSD in the beginning of their pregnancy, 6/11 continued Prazosin use during pregnancy after finding out they were pregnant and the remainder (5/11) discontinued prazosin during the first trimester after they found out they were pregnant. Dose information on Prazosin was not available. Their mean age (in years) was 33.1 with a standard deviation (SD) of 6.62. Mean BMI (kg/ m^2) was 32.3 with a SD of 5.44. Nine of the 11 patients (81.8%) came from an urban location, and 2/11(18.2%) of the patients came from a rural location.